The Brain Lesion and Neuromodulation Laboratory (BLNL) is seeking 1-2 undergraduate research assistants. The BLNL investigates brain mechanisms of behavior and cognition using lesion-deficit mapping and neuromodulation (electrical brain stimulation). The assistants will be asked to help with projects focused on neuropsychological outcomes after neurosurgery among patients with epilepsy, and/or pioneering a new test of working memory for use in various neuropsychological settings (acute stroke, standard outpatient exams, electrical stimulation mapping in patients with epilepsy). Duties may include: assisting with digitizing paper records of neuropsychological testing of patients with focal brain lesions, administering neuropsychological tests, and data entry.

Gain real-world experience, mentorship from industry professionals, and the opportunity to make a meaningful impact at a global science-driven company.

Join a multi-disciplinary research team including clinical neuropsychologists, audiologists and speech and hearing scientists studying the impact of hearing on quality of life in cochlear implant users. In this role, you will learn about clinical neuropsychology, hearing science, smartphone data collection technology, social network analysis and more.

Applications accepted until August 31st.

Researchers, it's that time of year. Invest in your growth by registering your research for academic credit! Click here to learn more.

Research Topic: Effect of chronic opioid use on early cardiovascular development. Up to 22% of pregnant women either receive opioid pain medications or misuse opioids, consequently exposing their fetuses to potential adverse outcomes such as congenital heart defects, stillbirths, and disrupted early cardiovascular development (eCVD). While cessation of opioid use might not be possible, effective and individualized pain management during pregnancy is critical and strongly warranted. However, the precise details of how opioid timing, dose, and type affect eCVD remain poorly understood. There is an urgent need to investigate the impact of opioids on eCVD in models that faithfully simulate human embryonic development. Without such knowledge, establishing a guide for opioid treatment during pregnancy to mitigate adverse cardiovascular outcomes in neonates remains unlikely.